Sales

9 Months Ended

May 31, 2023

Revenue from Contract with Customer [Abstract]

Sales

Sales

The following table summarizes the Company’s sales by segment and by major source (in millions):

	Three months ended May 31,				Nine months ended May 31,
	2023		2022		2023		2022
U.S. Retail Pharmacy
Pharmacy	$	20,898	$	19,656	$	60,991	$	60,581
Retail	6,968		7,039		21,657		21,814
Total	27,866		26,695		82,648		82,394
International
Pharmacy	924		901		2,690		2,876
Retail	1,769		1,618		5,412		5,294
Wholesale	2,880		2,786		8,311		8,516
Total	5,573		5,305		16,414		16,686
U.S. Healthcare	1,975		596		4,597		1,173
Corporate and Other 1	—		1		—		—
Walgreens Boots Alliance, Inc.	$	35,415	$	32,597	$	103,659	$	100,254

1.Includes certain eliminations.

See Note 18. Supplemental information for further information on receivables from contracts with customers.